Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of ...
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.